ADPT

NASDAQ · Life Sciences Tools & Services

Adaptive Biotechnologies

Mid-Cap Stocks Healthcare Stocks

$27.98

+1.15 (+4.29%)

As of Nov 7, 1:39 AM ET ·

ADPT News1 articles

Virax Biolabs Surges 183% on Exclusive Fosun Supply Pact

Virax Biolabs shares surged 183% after its UK subsidiary inked an exclusive supply deal with Fosun Diagnostics for the ImmuneSelect line, covering six Southeast Asian countries.